Donald M. Black
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Pharmaceutical Economics and Policy, BRCA gene mutations in cancer, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor(1995)484 cited
- → Comparison of One-Year Efficacy and Safety of Atorvastatin Versus Lovastatin in Primary Hypercholesterolemia(1997)234 cited
- → KP elements repress P-induced hybrid dysgenesis in Drosophila melanogaster.(1987)222 cited
- Closing in on a breast cancer gene on chromosome 17q.(1992)
- → A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia(1997)188 cited
- → Treating patients with documented atherosclerosis to national cholesterol education program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin(1998)185 cited
- → Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner(2001)170 cited
- → An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor(1998)162 cited
- → Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines(1999)124 cited
- → Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia(2001)121 cited